PARP12 and breast carcinoma: Regarding this aspect the observation that PARP12 levels inversely correlate with the survival rate of ER + breast cancer patients already treated with chemotherapy and/or hormone-based therapies is of particular interest, since it does not impinge on the survival rate of ER-negative breast cancer patients.